A Phase II, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus Bevacizumab and FOLFIRI in Previously Treated Advanced Inoperable Metastatic Colorectal Cancer CRC

Brief Summary

Type:
Colorectal

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT05330429

Study #:
STUDY00149288

Start Date:
Jun 11, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05330429

View Complete Trial Details & Eligibility at ClinicalTrials.gov